The growth rate remains consistent and if this continues I see no reason why we shouldn't see annual revenue at near $40 million by this time next year.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025